Assessing Computational Models for Pharmacogenomic Variant Interpretation
Assessment of several computational approaches using a dataset of pharmacogenomic variants with either clinical annotations or functional characterization by deep mutational scanning, with an additional focus on CYP2C9, a clinically relevant drug-metabolizing enzyme, indicates that computational models can complement i...